For the first time in decades, we have a new kind of schizophrenia drugCobenfy is a groundbreaking drug that targets muscarinic receptors, potentially offering a new treatment avenue for schizophrenia sufferers.
F.D.A. Approves the First New Schizophrenia Drug in DecadesCobenfy is the first new antipsychotic in decades, aiming to treat schizophrenia without severe side effects like weight gain.
For the first time in decades, we have a new kind of schizophrenia drugCobenfy is a groundbreaking drug that targets muscarinic receptors, potentially offering a new treatment avenue for schizophrenia sufferers.
F.D.A. Approves the First New Schizophrenia Drug in DecadesCobenfy is the first new antipsychotic in decades, aiming to treat schizophrenia without severe side effects like weight gain.